NPI 1891347167: Open Payments
NPI 1891347167. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 2 companies in 2025. Trend: 2023 $362 · 2024 $437 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
Products named: OTEZLA, AIRSUPRA, FARXIGA.
